Tech Company Financing Transactions
Transcarent Funding Round
General Catalyst and private investors joined a $125 million Series D capital raise for Transcarent. The round was announced on 3/26/2024.
Transaction Overview
Company Name
Announced On
3/26/2024
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Series D
Investors
General Catalyst (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
58 South Park St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Transcarent, our goal is to connect consumers with the right information, resources and tools to help them make the best medical and financial decisions for themselves and their families in a simplified, seamless experience. Sounds straightforward, but it fundamentally redesigns the delivery of health care to put the consumer and their needs first.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glen Tullman
Chief Medical Officer
Bipin Mistry
Chief Technical Officer
Jeffrey Dobro
President
Krishnan Sridharan
Vice President
Marin Hoffman
VP - Administration
Caitlin Fleming
VP - Bus. Development
Jamie Hall
VP - Engineering
Owen Tran
VP - Human Resources
Jennifer Pratt
VP - Product Management
Vikas Sabnani
Browse more venture capital transactions:
Prev: 3/26/2024: Goodbill venture capital transaction
Next: 3/26/2024: Popularium venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs